Detalles de la búsqueda
1.
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Circulation
; 113(17): 2089-96, 2006 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-16636176
2.
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
Circulation
; 114(10): 1020-7, 2006 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16923753
3.
Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).
J Card Fail
; 13(7): 530-40, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17826643
4.
Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.
J Cardiovasc Transl Res
; 6(4): 528-35, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23722357
5.
Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure.
Circ Heart Fail
; 4(3): 246-56, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21350055
Resultados
1 -
5
de 5
1
Próxima >
>>